Contrive Datum Insights has published "Telehealth Market Size, Share & Industry Analysis, By Product type (Monitors, Medical Peripheral Devices, Blood Pressure Meters, Blood Glucose Meters, Weighing Scales, Pulse Oximeters, Peak Flow Meters, ECG Monitors, Others, Standalone Software, Integrated Software, Remote Patient Monitoring, Real-Time Interactions, Store and Forward), Delivery mode (On-premise, Web-based, Cloud-based), End-use (Payers, Providers, Patients), Disease area (Psychiatry, Substance Use, Radiology, Endocrinology, Dermatology, Gastroenterology, Neurological Medicine, ENT, Cardiology, Oncology, Dental, Gynecology, General Medicine, Others), Service type (Tele-consultation, Tele-monitoring, Tele-education/Training, Tele-ICU), and Regional Forecast, 2026-2034". The study sizes the global telehealth market at USD 176.4 billion in 2025 and projects growth from USD 202.9 billion in 2026 to USD 762.69 billion by 2034, a compound annual growth rate of 18% across the forecast period.
Telehealth refers to the devices, software platforms and virtual care services that let patients and clinicians exchange health information and conduct consultations without both parties being in the same location. The category spans connected monitoring hardware such as blood pressure, glucose and cardiac monitors, the software platforms that host live video, audio and messaging based consultations, and remote patient monitoring programs that feed device data back to a care team between visits. Buyers include hospitals and health systems building virtual care programs, insurers extending coverage to remote consultations, and individual patients purchasing direct-to-consumer subscription services.
Expansion of remote patient monitoring and chronic disease management programs
Expansion of remote patient monitoring and chronic disease management programs is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 18% a year, the product type lines exposed to it move fastest: Store and Forward compounds at 23.3%, taking its share of revenue from 4% to 6% and its value from USD 7.06 billion to USD 45.76 billion.
On the upside, the study's bull case assumes reimbursement parity holds and expands into additional states and national health systems faster than the base case, and cloud migration among mid-size providers completes ahead of schedule, which would take 2034 revenue to USD 915.74 billion against the USD 762.69 billion base case.
On the downside, A rollback of telehealth reimbursement parity in one or more major markets pushes volume back toward in-person care and slows cloud migration among smaller providers, which would hold 2034 revenue to USD 610.28 billion. Standalone Software, which carries 10% of 2025 revenue, already grows at only 16.6% against the market's 18%, so the largest part of the base is also its slowest.
Key Players Compete on Remote Patient Monitoring Volume and Store and Forward Growth
Competition in the global telehealth market runs along the product type axis, not the regional one. Remote Patient Monitoring holds 16% of 2025 revenue at USD 28.22 billion and remains the largest line through 2034 at 22%, making it the position hardest for a challenger to take. Store and Forward, growing at 23.3%, is where share actually changes hands. A supplier established in one is not thereby established in the other, so a field of this size persists in a market of USD 176.4 billion.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Product type | Remote Patient Monitoring | 16% · USD 28.22 billion | — |
| Delivery mode | Cloud-based | 45% · USD 79.38 billion | — |
| End-use | Providers | 48% · USD 84.67 billion | Patients 19.1% |
| Disease area | Psychiatry | 22% · USD 38.81 billion | Oncology 22.2% |
| Service type | Tele-consultation | 52% · USD 91.73 billion | Tele-ICU 21.9% |
- North America was the largest region in 2025, holding 40% of global revenue at USD 70.56 billion and reaching USD 274.57 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 28% in 2025 to 33% in 2034, with revenue growing from USD 49.39 billion to USD 251.69 billion.
- Middle East and Africa stays the smallest contributor across the period: 4% of revenue in 2025 and 4.5% in 2034.
- No product type line grows faster than Store and Forward, at a projected 23.3%.
- The United States is the largest single country market at USD 59.98 billion in 2025, 34% of global revenue.
Every year from 2020 to 2034 is reported, with revenue and growth for each line across five axes: by product type, and by delivery mode, end-use, disease area and service type. The headline total carries bear, base and bull cases at USD 610.28 billion and USD 915.74 billion by 2034. The study also breaks out all five regions to country level, sets out the competitive landscape, and documents the method behind every estimate. Available as a PDF, with a free sample on request.